IE 11 is not supported. For an optimal experience visit our site on another browser.

  • Last-minute holiday shopping underway for millions across the US

    03:19

  • FAA temporarily bans drone flights over New York and New Jersey

    01:52

  • Now Playing

    FDA approves weight loss drug Zepbound for sleep apnea

    00:22

  • UP NEXT

    Delphi murders: Richard Allen sentenced to 130 years

    00:29

  • Mega Millions jackpot soars to a whopping $944 million

    00:31

  • New alert from CDC shows flu cases are on the rise across the US

    00:21

  • Traveling for the holidays? What to expect on roads and at airports

    02:18

  • Concerns grow in the US after attack on German Christmas market

    02:22

  • Biden expected to sign short-term funding bill to keep the government open

    01:23

  • Lawmakers pass bill to avoid a government shutdown

    02:11

  • Favorite foods, movies, more: Holiday traditions by the numbers

    03:44

  • Teen diagnosed with rare cancer meets Chiefs star Isiah Pacheco

    04:07

  • See the creative way this woman told her in-laws she was pregnant

    00:52

  • $825M up for grabs as Mega Millions jackpot continues to climb

    00:27

  • Royals hold annual pre-Christmas lunch with notable absences

    02:14

  • Record-breaking holiday travel builds on the roads and at airports

    03:16

  • Luigi Mangione hit with new charges that could carry death penalty

    02:23

  • Amazon workers strike at 7 facilities, targeting holiday delivery rush

    02:25

  • How a government shutdown could impact travel, deliveries, more

    02:07

  • Trump-backed funding bill fails in House as shutdown looms

    02:21

Popular weight loss drug Zepbound, which is already approved to treat obesity, now becomes the first drug to ever treat sleep apnea, a sleeping disorder that impacts nearly 40 million people.